RXMD - Progressive Care, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0683
-0.0010 (-1.37%)
As of 2:42PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close0.0692
Open0.0700
Bid0.00000 x 0
Ask0.00000 x 0
Day's Range0.0661 - 0.0700
52 Week Range0.0180 - 0.2660
Volume146,743
Avg. Volume681,222
Market Cap29.431M
Beta (3Y Monthly)-1.68
PE Ratio (TTM)N/A
EPS (TTM)-0.01600
Earnings DateNov 13, 2018 - Nov 19, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire6 days ago

    Progressive Care Releases Open Letter to Shareholders

    After reaching record revenues in 2017 of $20 million the Company moved forward on an agenda that would make us more resilient in the face of industry changes and push past our competitors in terms of service, expertise, and technology. Early in 2018, we planted the seeds of growth by filling record numbers of prescriptions and issuing an LOI for our first acquisition.

  • GlobeNewswire7 days ago

    Progressive Care Inc. Issues Update on Acquisition Process

    MIAMI, Jan. 16, 2019 -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today issued an update regarding the pharmacy.

  • GlobeNewswire8 days ago

    Progressive Care Inc. Announces Best December in Company History

    MIAMI, Jan. 15, 2019 -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue.

  • GlobeNewswire12 days ago

    Progressive Care Executes New Capital Funding Facility

    Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has entered into a new securities purchase agreement. Progressive Care has agreed to a secured promissory note providing $2.5 million in capital facility to the company, $1 million of which was funded on January 7, 2019 and $1.5 million will be available in tranches thereafter. The Company has secured this capital in advance of an ambitious 2019 agenda which includes logistical implementation of the company’s unique service offerings (DischargeRx, TelePharmacy, Full Service 340B Program), development of new product lines and digital technologies, expanded sales efforts of the core business, build-out of the recently acquired property, and acquisition support.

  • GlobeNewswire13 days ago

    Shital Mars CEO of Progressive Care Inc. Garners Coverage in Authority Magazine as a Hero of the Opioid Crisis

    Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered media coverage in Authority Magazine as a hero of the opioid crisis. In an interview titled Heroes Of The Opioid Crisis, published December 27, 2018 in Authority Magazine Mars discusses how she would like to a see a bill that limits the extent to which a patient can be denied coverage for necessary medications. Today insurance companies are restricting benefits to the point where a patient can no longer get coverage for outpatient pain management solutions other than prescription grade ibuprofen, or Tylenol.

  • GlobeNewswirelast month

    Entry into a Material Definitive Agreement

    The Company issued a convertible promissory note (the “Note”) in the amount of $300,000 to the Seller to fund a portion of the price for such purchase.  The Note bears interest at the rate of 10% per annum and is payable in full 27 months from the date of issuance. The outstanding principal and interest then payable under the Note is convertible into shares of the Company’s common stock 12 months after the date of issuance at the price per share equal to the average trading-price for the common stock during the three (3) trading day period ending on the latest complete trading day prior to the conversion date.

  • GlobeNewswirelast month

    Uptick Newswire Hosts Progressive Care Inc’s CEO to Discuss an Exciting New Acquisition Prospect and Company Growth

    At the start of the interview Jolly mentioned the letter of intent issued by Progressive Care Inc. to purchase a Florida based pharmacy with 2 operating locations. “We want to grow organically but we also want to grow through acquisition,” explains Mars. Mars went on to explain the company they intend to purchase has a lot of synergies with who Progressive Care Inc. is as a company, including a pharmacy in Orlando which is a big market for the company.

  • GlobeNewswire2 months ago

    Progressive Care Inc. Garners International News Coverage in Leading Trade Publications for Its Efforts to Improve Adherence

    Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered notable international media coverage in top pharmacy industry publication World Pharma Today stressing the importance of adherence and compliance in the space of medicine. In a contributed article titled “The Pharmacist Perspective: Medication Adherence & Compliance”, published November 26, 2018, in World Pharma Today, Mars focuses on adherence and its significance for patients who are prescribed medications.

  • GlobeNewswire2 months ago

    Progressive Care Signs Letter of Intent to Purchase Florida Based Pharmacy with $18 million in Annual Revenue

    Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has entered into a letter of intent to purchase a Florida based pharmacy with 2 operating locations. On November 27, 2018, Progressive Care executed a letter of intent to purchase a Florida based pharmacy with locations in Davie and Orlando, Florida. The target pharmacy had just under $16 million in revenue in 2017 and is projected to have approximately $18 million for 2018.

  • GlobeNewswire2 months ago

    Progressive Care Inc. Announces Record-Breaking October 2018

    MIAMI, Nov. 16, 2018 -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue.

  • GlobeNewswire2 months ago

    Progressive Care Inc. Reports Best Nine-Month Revenue Period in Company History in Q3 2018 Financial Filing

    Progressive Care Inc. (RXMD), a personalized healthcare services and technology company, today announced financial results for the quarter ending Sept. 30, 2018, as well as provided an overview of recent operational highlights along with updates on the Company’s strategies. Progressive Care dispensed 212,000 prescriptions during the nine-month period ending Sept. 30, 2018, an increase over the same period last year of 30%. During Q3 2018, the Company experienced continued growth over last year, showing a 6% increase in total revenue over Q3 2017.

  • GlobeNewswire2 months ago

    Progressive Care to Host Conference Call on Third Quarter 2018 Financial Results and Business Update on November 14th

    Progressive Care Inc. (RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Wednesday, November 14th, 2018. “I am excited to share the significant milestones that Progressive Care and our subsidiary PharmCo have experienced in the most recent quarter with our engaged investors and the public,” said S. Parikh Mars, CEO of Progressive Care Inc. “The company is experiencing an extremely positive outlook and growth trajectory and I couldn’t be more proud of our progress in Q3 and the year to date. In addition, interested parties have the opportunity to submit questions concerning the Company prior to the call to Stuart Smith at SmallCapVoice.Com, Inc. via email: ssmith@smallcapvoice.com by 3:00 PM eastern standard time on Monday, November, 12th, 2018.

  • GlobeNewswire3 months ago

    Progressive Care Inc. Garners International News Coverage in Top Pharmacy Trade Publication for Its Proprietary Tele-Pharmacy Platform

    Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered notable international media coverage in top pharmacy industry publication Pharmacy Times around the company’s proprietary new Tele-PharmCo platform. Progressive Care Inc. CEO S. Parikh Mars will give the first-ever live demonstration of the Company’s Tele-PharmCo platform during her presentation titled Tele-Pharmacy: Where Personalization Meets Tech at the 5th Annual Florida Telehealth Summit on November 8, 2018 from 3:15 p.m. – 4:15 p.m. ET at the Trade Winds Island Resort in St. Pete Beach, Florida. In an article published October 18, 2018, in Pharmacy Times, Mars discusses the beta launch of the company’s new proprietary tele-pharmacy software, Tele-PharmCo.

  • GlobeNewswire3 months ago

    Progressive Care Inc. CEO to Speak at 5th Annual Florida Telehealth Summit in St. Pete Beach, Florida

    MIAMI, Nov. 01, 2018 -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that the company will be attending and.